Bibliography
Found 109 results
Filters: Keyword is AIDS Dementia Complex [Clear All Filters]
White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 ;25(1):32-41.
Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology [Internet]. 2007 ;27:86-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17226745
. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 ;21(5):559-67.
Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 ;69(1):29-35.
A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology. 2013 ;81(17):1492-9.
Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.
Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis. PLoS One. 2016 ;11(5):e0155766.
. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.
Osteopontin is increased in HIV-associated dementia. The Journal of Infectious Diseases [Internet]. 2008 ;198:715-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18616394
. Neuropsychological, Neurovirological and Neuroimmune Aspects of Abnormal GABAergic Transmission in HIV Infection. J Neuroimmune Pharmacol. 2016 ;11(2):279-93.
. HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons. Sci Rep. 2019 ;9(1):8006.
. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014 ;28(11):1579-91.
. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Journal of Neurovirology [Internet]. 2007 ;13:23-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17454445
. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.
CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathology (Zurich, Switzerland) [Internet]. 2006 ;16(4):256-65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17107594
. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016 ;11(6):e0157160.
Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable. J Neurovirol. 2018 ;24(4):514-522.
. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011 ;25(14):1747-51.
Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology [Internet]. 2006 ;67:1867-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17130427
. Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res. 2016 ;14(4):324-30.
Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning. J Clin Exp Neuropsychol. 2017 ;39(9):842-853.
. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015 ;35(5):1921-38.
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders. J Neuroimmune Pharmacol. 2014 ;9(2):102-16.
. .